Get to know our products
Perspectum is a global expert in medical image analysis and software development with specialised imaging CRO capabilities for the identification and monitoring of non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC), inflammatory bowel disease (IBD), cancer, and type 2 diabetes.
Our mission is to improve the lives of patients by accelerating drug development with smart imaging technology. We want to fundamentally change clinical trials by using multi-parametric magnetic resonance imaging (mpMRI) to offer non-invasive, quantitative biomarkers that are standardised and accurate. This gives sponsors the enhanced data they need accurately detect early efficacy signals, reliably monitor patient response to treatment over time, and improve screening and stratification strategies to lower enrollment costs.